In summary, immunological control of cancer cells with high COX-2 expression by antigen-specific T cells may be less effective because of increased local release of IL4 and IDO and blunted interferon-gamma secretion by antigen-activated cytotoxic T cells. This evidence concerns the gene IDO1 and cancer.